Cannulation Site Complications Of Femoral Va-ecmo Support In Heart Transplantation And Role Of Sartorius Muscle Flap
Ameesh Isath,Suguru Ohira,Vasiliki Gregory,Igor Laskowski,Romeo Mateo,Sateesh Babu,Avi Levine,Stephen Pan,Abhay Dhand,Alan Gass,David Spielvogel,Masashi Kai
DOI: https://doi.org/10.1016/j.cardfail.2023.10.238
IF: 6.592
2024-01-01
Journal of Cardiac Failure
Abstract:Introduction Femoral veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is frequently used in heart transplant (HT) patients as either a bridge to HT or for primary graft dysfunction. However, wound infections of the arterial cannulation site can be fatal in immunosuppressed HT patients. The Sartorius muscle has been utilized as an in situ vascularized flap to cover the femoral vessels, which can prevent the progression of infection, improve local healing by reducing dead space, increasing blood flow, and reducing microbial counts at the wound site. We describe the femoral VA-ECMO complications, risk factors and role of of the Sartorius muscle flap after cardiac transplantation. Methods We reviewed HT patients who underwent peri-transplant femoral VA-ECMO at our institution from April 2011 to November 2022. Cannulation site complications were defined as any adverse events that occurred at the cannulation site, including infection, limb ischemia, wound dehiscence, fluid collection, and persistent lymphatic leak. Results Among the 34 patients requiring VA-ECMO peri-transplant, 16 (47%) experienced complications at the cannulation site (Table 1). The median duration of ECMO support was 6 days and comparable in both groups. The most common complication was cannulation site infection (n=10, 29.4%), with gram-negative bacteria (Klebsiella and Pseudomonas) being the most common. Other complications included non-healing wounds (n=3), persistent lymphatic leak (n=1), wound dehiscence (n=1), and limb ischemia (n=1). In a subgroup analysis of patients with cannulation site infection, patients who developed infection were more likely to have a higher body mass index (31.6 vs 27.3, p=0.02) with higher rates of renal failure and concomitant pneumonia (70% vs 25%, p=0.01, 40% vs 8.3%, p=0.03 respectively). Of the 16 patients with cannulation site complications, 11 (68.7%) received a Sartorius flap, while 5 (31.2%) were managed conservatively with antibiotics and vacuum-assisted closure therapy. The indications for Sartorius flap included groin infections in 9 patients, lymphatic leaks in 1 patient, and non-healing wound in 1 patient. Patients who underwent the Sartorius flap did not experience arterial complications except for one patient who developed subsequent E. coli infection and a thrombosed pseudoaneurysm. Conclusion Complications related to femoral VA-ECMO are common in HT patients, with infection being the most frequent. Higher BMI, renal failure, and concomitant pneumonia are potential risk factors for developing cannulation site infections. This is also the first report of the utilization of Sartorius muscle flap to prevent progression of infection, promote local healing and improve outcomes in HT recipients.
cardiac & cardiovascular systems